Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States

被引:81
|
作者
Willis, Jeffrey R. [1 ,2 ]
Doan, Quan V. [3 ]
Gleeson, Michelle [3 ]
Haskova, Zdenka [2 ]
Ramulu, Pradeep [4 ]
Morse, Lawrence [1 ]
Cantrell, Ronald A. [2 ]
机构
[1] Univ Calif Davis, Ctr Eye, 4860 Y St,Ste 2400, Sacramento, CA 95817 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Outcomes Insights Inc, Westlake Village, CA USA
[4] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA
关键词
PHYSICAL-ACTIVITY; PANRETINAL PHOTOCOAGULATION; INTRAVITREOUS RANIBIZUMAB; MACULAR EDEMA; PROGRESSION;
D O I
10.1001/jamaophthalmol.2017.2553
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
IMPORTANCE Among adults with diabetes in the United States, severe forms of diabetic retinopathy (DR) are significantly associated with a greater vision-related functional burden. OBJECTIVE To assess the functional burden of DR across severity levels in the United States. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study was based on 1004 participants 40 years or older with diabetes and valid ocular and sociodemographic outcomes in the National Health and Nutrition Examination Surveys (NHANES) (2005-2006 and 2007-2008). Diabetic retinopathy was based on fundus photograph grading, using the Early Treatment Diabetic Retinopathy Study severity scale. The analysis was performed from October 15, 2016, to June 15, 2017. MAIN OUTCOMES AND MEASURES Functional difficulties secondary to vision were assessed during a household questionnaire in which participants self-reported difficulty with reading, visuospatial tasks (ie, close-up work or finding things on a crowded shelf), mobility (ie, walking down steps, stairs, or curbs), and driving. The main outcome measure was vision-related functional burden, which was defined as present for individuals reporting moderate or greater difficulty in any of the aforementioned tasks. RESULTS Of the 1004 persons with diabetes analyzed for this study (mean age, 65.7 years [95% CI, 64.0-67.3 years]; 51.1% male [95% CI, 47.1-55.2] and 48.9% female [95% CI, 44.8-52.9]), the prevalence was 72.3% for no retinopathy, 25.4% for mild and moderate nonproliferative diabetic retinopathy (NPDR), and 2.3% for severe NPDR or proliferative diabetic retinopathy (PDR). The prevalence of vision-related functional burden was 20.2% (95% CI, 16.3%-24.1%) for those with no retinopathy, 20.4%(95% CI, 15.3%-27.8%) for those with mild and moderate NPDR, and 48.5%(95% CI, 25.6%-71.5%) for those with severe NPDR or PDR (P = .02). In multivariable analysis, the odds of vision-related functional burden were significantly greater among those with severe NPDR or PDR relative to those with no retinopathy (adjusted odds ratio [aOR], 3.59; 95% CI, 1.29-10.05; P = .02). Those with severe NPDR or PDR did not have a statistically significant greater odds of vision-related functional burden than did those with mild or moderate NPDR (aOR, 2.70; 95% CI, 0.93-7.78; P = .07). CONCLUSIONS AND RELEVANCE Among US adults with diabetes, approximately half of those with severe NPDR or PDR had difficulty with at least one visual function task. Moreover, vision-related functional burden was significantly greater among those with severe NPDR or PDR than among those with no retinopathy. These data suggest the importance of preventing severe forms of DR to mitigate the vision-related functional burden among US adults with diabetes. Future studies should complement our study by assessing the association of worsening retinopathy with objectively measured functional outcomes.
引用
收藏
页码:926 / 932
页数:7
相关论文
共 50 条
  • [31] Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema
    Bressler, Neil M.
    Varma, Rohit
    Suner, Ivan J.
    Dolan, Chantal M.
    Ward, James
    Ehrlich, Jason S.
    Colman, Shoshana
    Turpcu, Adam
    [J]. OPHTHALMOLOGY, 2014, 121 (12) : 2461 - 2472
  • [32] Associations between lipid abnormalities and diabetic retinopathy across a large United States national database
    Jeong, Hejin
    Maatouk, Christopher M.
    Russell, Matthew W.
    Singh, Rishi P.
    [J]. EYE, 2024, 38 (10) : 1870 - 1875
  • [33] Ten-Year Change in Vision-Related Quality of Life in Type 1 Diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy
    Hirai, Flavio E.
    Tielsch, James M.
    Klein, Barbara E. K.
    Klein, Ronald
    [J]. OPHTHALMOLOGY, 2011, 118 (02) : 353 - 358
  • [34] Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
    Ryan Lee
    Tien Y. Wong
    Charumathi Sabanayagam
    [J]. Eye and Vision, 2
  • [35] Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
    Lee, Ryan
    Wong, Tien Y.
    Sabanayagam, Charumathi
    [J]. EYE AND VISION, 2015, 2
  • [36] Distribution and associations of vision-related quality of life and functional vision of children with visual impairment
    Robertson, Alexandra O.
    Horvat-Gitsels, Lisanne A.
    Cortina-Borja, Mario
    Rahi, Jugnoo S.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (09) : 1325 - 1330
  • [37] Insights into Progression of Diabetic Retinopathy (DR) Severity Among Primary Care Patients with Diabetes in the United States
    Sahni, J.
    Lin, C. Y.
    Steffen, V.
    Haskova, Z.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (1_SUPPL) : 15 - 15
  • [38] The prevalence of diabetic retinopathy among adults in the United States
    Kempen, JH
    O'Colmam, BJ
    Leske, C
    Haffner, SM
    Klein, R
    Moss, SE
    Taylor, HR
    Hamman, RF
    West, SK
    Wang, JJ
    Congdon, NG
    Friedman, DS
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (04) : 552 - 563
  • [39] The Economic Burden of Vision Loss and Blindness in the United States
    Rein, David B.
    Wittenborn, John S.
    Zhang, Ping
    Sublett, Farah
    Lamuda, Phoebe A.
    Lundeen, Elizabeth A.
    Saaddine, Jinan
    [J]. OPHTHALMOLOGY, 2022, 129 (04) : 369 - 378
  • [40] PLASMA THROMBOMODULIN LEVELS INCREASE WITH THE SEVERITY OF THE DIABETIC-RETINOPATHY
    SEIGNEUR, M
    DUFOURCQ, P
    GIN, H
    DELAFAYE, C
    AMIRAL, J
    PRUVOST, A
    BOISSEAU, MR
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (05) : 845 - 846